Global IVD Infectious Diseases Market Growth (Status and Outlook) 2025-2031
According to this study, the global IVD Infectious Diseases market size will reach US$ 23460 million by 2031.
In Vitro Diagnostics (IVDs) are medical devices and accessories used to perform tests on samples, (e.g., blood, urine and tissue that has been taken from the human body) in order to help detect infection, Diagnose a medical condition and Prevent disease.
United States market for IVD Infectious Diseases is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for IVD Infectious Diseases is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for IVD Infectious Diseases is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key IVD Infectious Diseases players cover BD, BioMerieux, Abbott, Quidel, Gen-Probe, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “IVD Infectious Diseases Industry Forecast” looks at past sales and reviews total world IVD Infectious Diseases sales in 2024, providing a comprehensive analysis by region and market sector of projected IVD Infectious Diseases sales for 2025 through 2031. With IVD Infectious Diseases sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world IVD Infectious Diseases industry.
This Insight Report provides a comprehensive analysis of the global IVD Infectious Diseases landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on IVD Infectious Diseases portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global IVD Infectious Diseases market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for IVD Infectious Diseases and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global IVD Infectious Diseases.
This report presents a comprehensive overview, market shares, and growth opportunities of IVD Infectious Diseases market by product type, application, key players and key regions and countries.
Segmentation by Type:
In Vitro Diagnostics (IVDs) are medical devices and accessories used to perform tests on samples, (e.g., blood, urine and tissue that has been taken from the human body) in order to help detect infection, Diagnose a medical condition and Prevent disease.
United States market for IVD Infectious Diseases is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for IVD Infectious Diseases is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for IVD Infectious Diseases is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key IVD Infectious Diseases players cover BD, BioMerieux, Abbott, Quidel, Gen-Probe, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “IVD Infectious Diseases Industry Forecast” looks at past sales and reviews total world IVD Infectious Diseases sales in 2024, providing a comprehensive analysis by region and market sector of projected IVD Infectious Diseases sales for 2025 through 2031. With IVD Infectious Diseases sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world IVD Infectious Diseases industry.
This Insight Report provides a comprehensive analysis of the global IVD Infectious Diseases landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on IVD Infectious Diseases portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global IVD Infectious Diseases market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for IVD Infectious Diseases and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global IVD Infectious Diseases.
This report presents a comprehensive overview, market shares, and growth opportunities of IVD Infectious Diseases market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Immunochemistry
- Molecular Diagnostics
- Clinical Laboratories
- Diagnostic Centers
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- BD
- BioMerieux
- Abbott
- Quidel
- Gen-Probe
- Abbott
- Danaher
- Sysmex
- Orasure
- Hologic
- Cepheid
- Qiagen
- Roche Diagnostics
- Siemens Healthcare
- Bio-Rad Laboratories
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global IVD Infectious Diseases Market Size (2020-2031)
2.1.2 IVD Infectious Diseases Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for IVD Infectious Diseases by Country/Region (2020, 2024 & 2031)
2.2 IVD Infectious Diseases Segment by Type
2.2.1 Immunochemistry
2.2.2 Molecular Diagnostics
2.3 IVD Infectious Diseases Market Size by Type
2.3.1 IVD Infectious Diseases Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global IVD Infectious Diseases Market Size Market Share by Type (2020-2025)
2.4 IVD Infectious Diseases Segment by Application
2.4.1 Clinical Laboratories
2.4.2 Diagnostic Centers
2.5 IVD Infectious Diseases Market Size by Application
2.5.1 IVD Infectious Diseases Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global IVD Infectious Diseases Market Size Market Share by Application (2020-2025)
3 IVD INFECTIOUS DISEASES MARKET SIZE BY PLAYER
3.1 IVD Infectious Diseases Market Size Market Share by Player
3.1.1 Global IVD Infectious Diseases Revenue by Player (2020-2025)
3.1.2 Global IVD Infectious Diseases Revenue Market Share by Player (2020-2025)
3.2 Global IVD Infectious Diseases Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 IVD INFECTIOUS DISEASES BY REGION
4.1 IVD Infectious Diseases Market Size by Region (2020-2025)
4.2 Global IVD Infectious Diseases Annual Revenue by Country/Region (2020-2025)
4.3 Americas IVD Infectious Diseases Market Size Growth (2020-2025)
4.4 APAC IVD Infectious Diseases Market Size Growth (2020-2025)
4.5 Europe IVD Infectious Diseases Market Size Growth (2020-2025)
4.6 Middle East & Africa IVD Infectious Diseases Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas IVD Infectious Diseases Market Size by Country (2020-2025)
5.2 Americas IVD Infectious Diseases Market Size by Type (2020-2025)
5.3 Americas IVD Infectious Diseases Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC IVD Infectious Diseases Market Size by Region (2020-2025)
6.2 APAC IVD Infectious Diseases Market Size by Type (2020-2025)
6.3 APAC IVD Infectious Diseases Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe IVD Infectious Diseases Market Size by Country (2020-2025)
7.2 Europe IVD Infectious Diseases Market Size by Type (2020-2025)
7.3 Europe IVD Infectious Diseases Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa IVD Infectious Diseases by Region (2020-2025)
8.2 Middle East & Africa IVD Infectious Diseases Market Size by Type (2020-2025)
8.3 Middle East & Africa IVD Infectious Diseases Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL IVD INFECTIOUS DISEASES MARKET FORECAST
10.1 Global IVD Infectious Diseases Forecast by Region (2026-2031)
10.1.1 Global IVD Infectious Diseases Forecast by Region (2026-2031)
10.1.2 Americas IVD Infectious Diseases Forecast
10.1.3 APAC IVD Infectious Diseases Forecast
10.1.4 Europe IVD Infectious Diseases Forecast
10.1.5 Middle East & Africa IVD Infectious Diseases Forecast
10.2 Americas IVD Infectious Diseases Forecast by Country (2026-2031)
10.2.1 United States Market IVD Infectious Diseases Forecast
10.2.2 Canada Market IVD Infectious Diseases Forecast
10.2.3 Mexico Market IVD Infectious Diseases Forecast
10.2.4 Brazil Market IVD Infectious Diseases Forecast
10.3 APAC IVD Infectious Diseases Forecast by Region (2026-2031)
10.3.1 China IVD Infectious Diseases Market Forecast
10.3.2 Japan Market IVD Infectious Diseases Forecast
10.3.3 Korea Market IVD Infectious Diseases Forecast
10.3.4 Southeast Asia Market IVD Infectious Diseases Forecast
10.3.5 India Market IVD Infectious Diseases Forecast
10.3.6 Australia Market IVD Infectious Diseases Forecast
10.4 Europe IVD Infectious Diseases Forecast by Country (2026-2031)
10.4.1 Germany Market IVD Infectious Diseases Forecast
10.4.2 France Market IVD Infectious Diseases Forecast
10.4.3 UK Market IVD Infectious Diseases Forecast
10.4.4 Italy Market IVD Infectious Diseases Forecast
10.4.5 Russia Market IVD Infectious Diseases Forecast
10.5 Middle East & Africa IVD Infectious Diseases Forecast by Region (2026-2031)
10.5.1 Egypt Market IVD Infectious Diseases Forecast
10.5.2 South Africa Market IVD Infectious Diseases Forecast
10.5.3 Israel Market IVD Infectious Diseases Forecast
10.5.4 Turkey Market IVD Infectious Diseases Forecast
10.6 Global IVD Infectious Diseases Forecast by Type (2026-2031)
10.7 Global IVD Infectious Diseases Forecast by Application (2026-2031)
10.7.1 GCC Countries Market IVD Infectious Diseases Forecast
11 KEY PLAYERS ANALYSIS
11.1 BD
11.1.1 BD Company Information
11.1.2 BD IVD Infectious Diseases Product Offered
11.1.3 BD IVD Infectious Diseases Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 BD Main Business Overview
11.1.5 BD Latest Developments
11.2 BioMerieux
11.2.1 BioMerieux Company Information
11.2.2 BioMerieux IVD Infectious Diseases Product Offered
11.2.3 BioMerieux IVD Infectious Diseases Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 BioMerieux Main Business Overview
11.2.5 BioMerieux Latest Developments
11.3 Abbott
11.3.1 Abbott Company Information
11.3.2 Abbott IVD Infectious Diseases Product Offered
11.3.3 Abbott IVD Infectious Diseases Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Abbott Main Business Overview
11.3.5 Abbott Latest Developments
11.4 Quidel
11.4.1 Quidel Company Information
11.4.2 Quidel IVD Infectious Diseases Product Offered
11.4.3 Quidel IVD Infectious Diseases Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Quidel Main Business Overview
11.4.5 Quidel Latest Developments
11.5 Gen-Probe
11.5.1 Gen-Probe Company Information
11.5.2 Gen-Probe IVD Infectious Diseases Product Offered
11.5.3 Gen-Probe IVD Infectious Diseases Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Gen-Probe Main Business Overview
11.5.5 Gen-Probe Latest Developments
11.6 Abbott
11.6.1 Abbott Company Information
11.6.2 Abbott IVD Infectious Diseases Product Offered
11.6.3 Abbott IVD Infectious Diseases Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Abbott Main Business Overview
11.6.5 Abbott Latest Developments
11.7 Danaher
11.7.1 Danaher Company Information
11.7.2 Danaher IVD Infectious Diseases Product Offered
11.7.3 Danaher IVD Infectious Diseases Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Danaher Main Business Overview
11.7.5 Danaher Latest Developments
11.8 Sysmex
11.8.1 Sysmex Company Information
11.8.2 Sysmex IVD Infectious Diseases Product Offered
11.8.3 Sysmex IVD Infectious Diseases Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Sysmex Main Business Overview
11.8.5 Sysmex Latest Developments
11.9 Orasure
11.9.1 Orasure Company Information
11.9.2 Orasure IVD Infectious Diseases Product Offered
11.9.3 Orasure IVD Infectious Diseases Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Orasure Main Business Overview
11.9.5 Orasure Latest Developments
11.10 Hologic
11.10.1 Hologic Company Information
11.10.2 Hologic IVD Infectious Diseases Product Offered
11.10.3 Hologic IVD Infectious Diseases Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Hologic Main Business Overview
11.10.5 Hologic Latest Developments
11.11 Cepheid
11.11.1 Cepheid Company Information
11.11.2 Cepheid IVD Infectious Diseases Product Offered
11.11.3 Cepheid IVD Infectious Diseases Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Cepheid Main Business Overview
11.11.5 Cepheid Latest Developments
11.12 Qiagen
11.12.1 Qiagen Company Information
11.12.2 Qiagen IVD Infectious Diseases Product Offered
11.12.3 Qiagen IVD Infectious Diseases Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Qiagen Main Business Overview
11.12.5 Qiagen Latest Developments
11.13 Roche Diagnostics
11.13.1 Roche Diagnostics Company Information
11.13.2 Roche Diagnostics IVD Infectious Diseases Product Offered
11.13.3 Roche Diagnostics IVD Infectious Diseases Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Roche Diagnostics Main Business Overview
11.13.5 Roche Diagnostics Latest Developments
11.14 Siemens Healthcare
11.14.1 Siemens Healthcare Company Information
11.14.2 Siemens Healthcare IVD Infectious Diseases Product Offered
11.14.3 Siemens Healthcare IVD Infectious Diseases Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Siemens Healthcare Main Business Overview
11.14.5 Siemens Healthcare Latest Developments
11.15 Bio-Rad Laboratories
11.15.1 Bio-Rad Laboratories Company Information
11.15.2 Bio-Rad Laboratories IVD Infectious Diseases Product Offered
11.15.3 Bio-Rad Laboratories IVD Infectious Diseases Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Bio-Rad Laboratories Main Business Overview
11.15.5 Bio-Rad Laboratories Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global IVD Infectious Diseases Market Size (2020-2031)
2.1.2 IVD Infectious Diseases Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for IVD Infectious Diseases by Country/Region (2020, 2024 & 2031)
2.2 IVD Infectious Diseases Segment by Type
2.2.1 Immunochemistry
2.2.2 Molecular Diagnostics
2.3 IVD Infectious Diseases Market Size by Type
2.3.1 IVD Infectious Diseases Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global IVD Infectious Diseases Market Size Market Share by Type (2020-2025)
2.4 IVD Infectious Diseases Segment by Application
2.4.1 Clinical Laboratories
2.4.2 Diagnostic Centers
2.5 IVD Infectious Diseases Market Size by Application
2.5.1 IVD Infectious Diseases Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global IVD Infectious Diseases Market Size Market Share by Application (2020-2025)
3 IVD INFECTIOUS DISEASES MARKET SIZE BY PLAYER
3.1 IVD Infectious Diseases Market Size Market Share by Player
3.1.1 Global IVD Infectious Diseases Revenue by Player (2020-2025)
3.1.2 Global IVD Infectious Diseases Revenue Market Share by Player (2020-2025)
3.2 Global IVD Infectious Diseases Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 IVD INFECTIOUS DISEASES BY REGION
4.1 IVD Infectious Diseases Market Size by Region (2020-2025)
4.2 Global IVD Infectious Diseases Annual Revenue by Country/Region (2020-2025)
4.3 Americas IVD Infectious Diseases Market Size Growth (2020-2025)
4.4 APAC IVD Infectious Diseases Market Size Growth (2020-2025)
4.5 Europe IVD Infectious Diseases Market Size Growth (2020-2025)
4.6 Middle East & Africa IVD Infectious Diseases Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas IVD Infectious Diseases Market Size by Country (2020-2025)
5.2 Americas IVD Infectious Diseases Market Size by Type (2020-2025)
5.3 Americas IVD Infectious Diseases Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC IVD Infectious Diseases Market Size by Region (2020-2025)
6.2 APAC IVD Infectious Diseases Market Size by Type (2020-2025)
6.3 APAC IVD Infectious Diseases Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe IVD Infectious Diseases Market Size by Country (2020-2025)
7.2 Europe IVD Infectious Diseases Market Size by Type (2020-2025)
7.3 Europe IVD Infectious Diseases Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa IVD Infectious Diseases by Region (2020-2025)
8.2 Middle East & Africa IVD Infectious Diseases Market Size by Type (2020-2025)
8.3 Middle East & Africa IVD Infectious Diseases Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL IVD INFECTIOUS DISEASES MARKET FORECAST
10.1 Global IVD Infectious Diseases Forecast by Region (2026-2031)
10.1.1 Global IVD Infectious Diseases Forecast by Region (2026-2031)
10.1.2 Americas IVD Infectious Diseases Forecast
10.1.3 APAC IVD Infectious Diseases Forecast
10.1.4 Europe IVD Infectious Diseases Forecast
10.1.5 Middle East & Africa IVD Infectious Diseases Forecast
10.2 Americas IVD Infectious Diseases Forecast by Country (2026-2031)
10.2.1 United States Market IVD Infectious Diseases Forecast
10.2.2 Canada Market IVD Infectious Diseases Forecast
10.2.3 Mexico Market IVD Infectious Diseases Forecast
10.2.4 Brazil Market IVD Infectious Diseases Forecast
10.3 APAC IVD Infectious Diseases Forecast by Region (2026-2031)
10.3.1 China IVD Infectious Diseases Market Forecast
10.3.2 Japan Market IVD Infectious Diseases Forecast
10.3.3 Korea Market IVD Infectious Diseases Forecast
10.3.4 Southeast Asia Market IVD Infectious Diseases Forecast
10.3.5 India Market IVD Infectious Diseases Forecast
10.3.6 Australia Market IVD Infectious Diseases Forecast
10.4 Europe IVD Infectious Diseases Forecast by Country (2026-2031)
10.4.1 Germany Market IVD Infectious Diseases Forecast
10.4.2 France Market IVD Infectious Diseases Forecast
10.4.3 UK Market IVD Infectious Diseases Forecast
10.4.4 Italy Market IVD Infectious Diseases Forecast
10.4.5 Russia Market IVD Infectious Diseases Forecast
10.5 Middle East & Africa IVD Infectious Diseases Forecast by Region (2026-2031)
10.5.1 Egypt Market IVD Infectious Diseases Forecast
10.5.2 South Africa Market IVD Infectious Diseases Forecast
10.5.3 Israel Market IVD Infectious Diseases Forecast
10.5.4 Turkey Market IVD Infectious Diseases Forecast
10.6 Global IVD Infectious Diseases Forecast by Type (2026-2031)
10.7 Global IVD Infectious Diseases Forecast by Application (2026-2031)
10.7.1 GCC Countries Market IVD Infectious Diseases Forecast
11 KEY PLAYERS ANALYSIS
11.1 BD
11.1.1 BD Company Information
11.1.2 BD IVD Infectious Diseases Product Offered
11.1.3 BD IVD Infectious Diseases Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 BD Main Business Overview
11.1.5 BD Latest Developments
11.2 BioMerieux
11.2.1 BioMerieux Company Information
11.2.2 BioMerieux IVD Infectious Diseases Product Offered
11.2.3 BioMerieux IVD Infectious Diseases Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 BioMerieux Main Business Overview
11.2.5 BioMerieux Latest Developments
11.3 Abbott
11.3.1 Abbott Company Information
11.3.2 Abbott IVD Infectious Diseases Product Offered
11.3.3 Abbott IVD Infectious Diseases Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Abbott Main Business Overview
11.3.5 Abbott Latest Developments
11.4 Quidel
11.4.1 Quidel Company Information
11.4.2 Quidel IVD Infectious Diseases Product Offered
11.4.3 Quidel IVD Infectious Diseases Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Quidel Main Business Overview
11.4.5 Quidel Latest Developments
11.5 Gen-Probe
11.5.1 Gen-Probe Company Information
11.5.2 Gen-Probe IVD Infectious Diseases Product Offered
11.5.3 Gen-Probe IVD Infectious Diseases Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Gen-Probe Main Business Overview
11.5.5 Gen-Probe Latest Developments
11.6 Abbott
11.6.1 Abbott Company Information
11.6.2 Abbott IVD Infectious Diseases Product Offered
11.6.3 Abbott IVD Infectious Diseases Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Abbott Main Business Overview
11.6.5 Abbott Latest Developments
11.7 Danaher
11.7.1 Danaher Company Information
11.7.2 Danaher IVD Infectious Diseases Product Offered
11.7.3 Danaher IVD Infectious Diseases Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Danaher Main Business Overview
11.7.5 Danaher Latest Developments
11.8 Sysmex
11.8.1 Sysmex Company Information
11.8.2 Sysmex IVD Infectious Diseases Product Offered
11.8.3 Sysmex IVD Infectious Diseases Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Sysmex Main Business Overview
11.8.5 Sysmex Latest Developments
11.9 Orasure
11.9.1 Orasure Company Information
11.9.2 Orasure IVD Infectious Diseases Product Offered
11.9.3 Orasure IVD Infectious Diseases Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Orasure Main Business Overview
11.9.5 Orasure Latest Developments
11.10 Hologic
11.10.1 Hologic Company Information
11.10.2 Hologic IVD Infectious Diseases Product Offered
11.10.3 Hologic IVD Infectious Diseases Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Hologic Main Business Overview
11.10.5 Hologic Latest Developments
11.11 Cepheid
11.11.1 Cepheid Company Information
11.11.2 Cepheid IVD Infectious Diseases Product Offered
11.11.3 Cepheid IVD Infectious Diseases Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Cepheid Main Business Overview
11.11.5 Cepheid Latest Developments
11.12 Qiagen
11.12.1 Qiagen Company Information
11.12.2 Qiagen IVD Infectious Diseases Product Offered
11.12.3 Qiagen IVD Infectious Diseases Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Qiagen Main Business Overview
11.12.5 Qiagen Latest Developments
11.13 Roche Diagnostics
11.13.1 Roche Diagnostics Company Information
11.13.2 Roche Diagnostics IVD Infectious Diseases Product Offered
11.13.3 Roche Diagnostics IVD Infectious Diseases Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Roche Diagnostics Main Business Overview
11.13.5 Roche Diagnostics Latest Developments
11.14 Siemens Healthcare
11.14.1 Siemens Healthcare Company Information
11.14.2 Siemens Healthcare IVD Infectious Diseases Product Offered
11.14.3 Siemens Healthcare IVD Infectious Diseases Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Siemens Healthcare Main Business Overview
11.14.5 Siemens Healthcare Latest Developments
11.15 Bio-Rad Laboratories
11.15.1 Bio-Rad Laboratories Company Information
11.15.2 Bio-Rad Laboratories IVD Infectious Diseases Product Offered
11.15.3 Bio-Rad Laboratories IVD Infectious Diseases Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Bio-Rad Laboratories Main Business Overview
11.15.5 Bio-Rad Laboratories Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. IVD Infectious Diseases Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. IVD Infectious Diseases Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Immunochemistry
Table 4. Major Players of Molecular Diagnostics
Table 5. IVD Infectious Diseases Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global IVD Infectious Diseases Market Size by Type (2020-2025) & ($ millions)
Table 7. Global IVD Infectious Diseases Market Size Market Share by Type (2020-2025)
Table 8. IVD Infectious Diseases Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global IVD Infectious Diseases Market Size by Application (2020-2025) & ($ millions)
Table 10. Global IVD Infectious Diseases Market Size Market Share by Application (2020-2025)
Table 11. Global IVD Infectious Diseases Revenue by Player (2020-2025) & ($ millions)
Table 12. Global IVD Infectious Diseases Revenue Market Share by Player (2020-2025)
Table 13. IVD Infectious Diseases Key Players Head office and Products Offered
Table 14. IVD Infectious Diseases Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global IVD Infectious Diseases Market Size by Region (2020-2025) & ($ millions)
Table 18. Global IVD Infectious Diseases Market Size Market Share by Region (2020-2025)
Table 19. Global IVD Infectious Diseases Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global IVD Infectious Diseases Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas IVD Infectious Diseases Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas IVD Infectious Diseases Market Size Market Share by Country (2020-2025)
Table 23. Americas IVD Infectious Diseases Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas IVD Infectious Diseases Market Size Market Share by Type (2020-2025)
Table 25. Americas IVD Infectious Diseases Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas IVD Infectious Diseases Market Size Market Share by Application (2020-2025)
Table 27. APAC IVD Infectious Diseases Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC IVD Infectious Diseases Market Size Market Share by Region (2020-2025)
Table 29. APAC IVD Infectious Diseases Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC IVD Infectious Diseases Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe IVD Infectious Diseases Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe IVD Infectious Diseases Market Size Market Share by Country (2020-2025)
Table 33. Europe IVD Infectious Diseases Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe IVD Infectious Diseases Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa IVD Infectious Diseases Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa IVD Infectious Diseases Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa IVD Infectious Diseases Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of IVD Infectious Diseases
Table 39. Key Market Challenges & Risks of IVD Infectious Diseases
Table 40. Key Industry Trends of IVD Infectious Diseases
Table 41. Global IVD Infectious Diseases Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global IVD Infectious Diseases Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global IVD Infectious Diseases Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global IVD Infectious Diseases Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. BD Details, Company Type, IVD Infectious Diseases Area Served and Its Competitors
Table 46. BD IVD Infectious Diseases Product Offered
Table 47. BD IVD Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. BD Main Business
Table 49. BD Latest Developments
Table 50. BioMerieux Details, Company Type, IVD Infectious Diseases Area Served and Its Competitors
Table 51. BioMerieux IVD Infectious Diseases Product Offered
Table 52. BioMerieux IVD Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. BioMerieux Main Business
Table 54. BioMerieux Latest Developments
Table 55. Abbott Details, Company Type, IVD Infectious Diseases Area Served and Its Competitors
Table 56. Abbott IVD Infectious Diseases Product Offered
Table 57. Abbott IVD Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Abbott Main Business
Table 59. Abbott Latest Developments
Table 60. Quidel Details, Company Type, IVD Infectious Diseases Area Served and Its Competitors
Table 61. Quidel IVD Infectious Diseases Product Offered
Table 62. Quidel IVD Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Quidel Main Business
Table 64. Quidel Latest Developments
Table 65. Gen-Probe Details, Company Type, IVD Infectious Diseases Area Served and Its Competitors
Table 66. Gen-Probe IVD Infectious Diseases Product Offered
Table 67. Gen-Probe IVD Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Gen-Probe Main Business
Table 69. Gen-Probe Latest Developments
Table 70. Abbott Details, Company Type, IVD Infectious Diseases Area Served and Its Competitors
Table 71. Abbott IVD Infectious Diseases Product Offered
Table 72. Abbott IVD Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Abbott Main Business
Table 74. Abbott Latest Developments
Table 75. Danaher Details, Company Type, IVD Infectious Diseases Area Served and Its Competitors
Table 76. Danaher IVD Infectious Diseases Product Offered
Table 77. Danaher IVD Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Danaher Main Business
Table 79. Danaher Latest Developments
Table 80. Sysmex Details, Company Type, IVD Infectious Diseases Area Served and Its Competitors
Table 81. Sysmex IVD Infectious Diseases Product Offered
Table 82. Sysmex IVD Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Sysmex Main Business
Table 84. Sysmex Latest Developments
Table 85. Orasure Details, Company Type, IVD Infectious Diseases Area Served and Its Competitors
Table 86. Orasure IVD Infectious Diseases Product Offered
Table 87. Orasure IVD Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Orasure Main Business
Table 89. Orasure Latest Developments
Table 90. Hologic Details, Company Type, IVD Infectious Diseases Area Served and Its Competitors
Table 91. Hologic IVD Infectious Diseases Product Offered
Table 92. Hologic IVD Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Hologic Main Business
Table 94. Hologic Latest Developments
Table 95. Cepheid Details, Company Type, IVD Infectious Diseases Area Served and Its Competitors
Table 96. Cepheid IVD Infectious Diseases Product Offered
Table 97. Cepheid IVD Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Cepheid Main Business
Table 99. Cepheid Latest Developments
Table 100. Qiagen Details, Company Type, IVD Infectious Diseases Area Served and Its Competitors
Table 101. Qiagen IVD Infectious Diseases Product Offered
Table 102. Qiagen IVD Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Qiagen Main Business
Table 104. Qiagen Latest Developments
Table 105. Roche Diagnostics Details, Company Type, IVD Infectious Diseases Area Served and Its Competitors
Table 106. Roche Diagnostics IVD Infectious Diseases Product Offered
Table 107. Roche Diagnostics IVD Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. Roche Diagnostics Main Business
Table 109. Roche Diagnostics Latest Developments
Table 110. Siemens Healthcare Details, Company Type, IVD Infectious Diseases Area Served and Its Competitors
Table 111. Siemens Healthcare IVD Infectious Diseases Product Offered
Table 112. Siemens Healthcare IVD Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Siemens Healthcare Main Business
Table 114. Siemens Healthcare Latest Developments
Table 115. Bio-Rad Laboratories Details, Company Type, IVD Infectious Diseases Area Served and Its Competitors
Table 116. Bio-Rad Laboratories IVD Infectious Diseases Product Offered
Table 117. Bio-Rad Laboratories IVD Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. Bio-Rad Laboratories Main Business
Table 119. Bio-Rad Laboratories Latest Developments
Table 1. IVD Infectious Diseases Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. IVD Infectious Diseases Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Immunochemistry
Table 4. Major Players of Molecular Diagnostics
Table 5. IVD Infectious Diseases Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global IVD Infectious Diseases Market Size by Type (2020-2025) & ($ millions)
Table 7. Global IVD Infectious Diseases Market Size Market Share by Type (2020-2025)
Table 8. IVD Infectious Diseases Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global IVD Infectious Diseases Market Size by Application (2020-2025) & ($ millions)
Table 10. Global IVD Infectious Diseases Market Size Market Share by Application (2020-2025)
Table 11. Global IVD Infectious Diseases Revenue by Player (2020-2025) & ($ millions)
Table 12. Global IVD Infectious Diseases Revenue Market Share by Player (2020-2025)
Table 13. IVD Infectious Diseases Key Players Head office and Products Offered
Table 14. IVD Infectious Diseases Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global IVD Infectious Diseases Market Size by Region (2020-2025) & ($ millions)
Table 18. Global IVD Infectious Diseases Market Size Market Share by Region (2020-2025)
Table 19. Global IVD Infectious Diseases Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global IVD Infectious Diseases Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas IVD Infectious Diseases Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas IVD Infectious Diseases Market Size Market Share by Country (2020-2025)
Table 23. Americas IVD Infectious Diseases Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas IVD Infectious Diseases Market Size Market Share by Type (2020-2025)
Table 25. Americas IVD Infectious Diseases Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas IVD Infectious Diseases Market Size Market Share by Application (2020-2025)
Table 27. APAC IVD Infectious Diseases Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC IVD Infectious Diseases Market Size Market Share by Region (2020-2025)
Table 29. APAC IVD Infectious Diseases Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC IVD Infectious Diseases Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe IVD Infectious Diseases Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe IVD Infectious Diseases Market Size Market Share by Country (2020-2025)
Table 33. Europe IVD Infectious Diseases Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe IVD Infectious Diseases Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa IVD Infectious Diseases Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa IVD Infectious Diseases Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa IVD Infectious Diseases Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of IVD Infectious Diseases
Table 39. Key Market Challenges & Risks of IVD Infectious Diseases
Table 40. Key Industry Trends of IVD Infectious Diseases
Table 41. Global IVD Infectious Diseases Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global IVD Infectious Diseases Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global IVD Infectious Diseases Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global IVD Infectious Diseases Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. BD Details, Company Type, IVD Infectious Diseases Area Served and Its Competitors
Table 46. BD IVD Infectious Diseases Product Offered
Table 47. BD IVD Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. BD Main Business
Table 49. BD Latest Developments
Table 50. BioMerieux Details, Company Type, IVD Infectious Diseases Area Served and Its Competitors
Table 51. BioMerieux IVD Infectious Diseases Product Offered
Table 52. BioMerieux IVD Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. BioMerieux Main Business
Table 54. BioMerieux Latest Developments
Table 55. Abbott Details, Company Type, IVD Infectious Diseases Area Served and Its Competitors
Table 56. Abbott IVD Infectious Diseases Product Offered
Table 57. Abbott IVD Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Abbott Main Business
Table 59. Abbott Latest Developments
Table 60. Quidel Details, Company Type, IVD Infectious Diseases Area Served and Its Competitors
Table 61. Quidel IVD Infectious Diseases Product Offered
Table 62. Quidel IVD Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Quidel Main Business
Table 64. Quidel Latest Developments
Table 65. Gen-Probe Details, Company Type, IVD Infectious Diseases Area Served and Its Competitors
Table 66. Gen-Probe IVD Infectious Diseases Product Offered
Table 67. Gen-Probe IVD Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Gen-Probe Main Business
Table 69. Gen-Probe Latest Developments
Table 70. Abbott Details, Company Type, IVD Infectious Diseases Area Served and Its Competitors
Table 71. Abbott IVD Infectious Diseases Product Offered
Table 72. Abbott IVD Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Abbott Main Business
Table 74. Abbott Latest Developments
Table 75. Danaher Details, Company Type, IVD Infectious Diseases Area Served and Its Competitors
Table 76. Danaher IVD Infectious Diseases Product Offered
Table 77. Danaher IVD Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Danaher Main Business
Table 79. Danaher Latest Developments
Table 80. Sysmex Details, Company Type, IVD Infectious Diseases Area Served and Its Competitors
Table 81. Sysmex IVD Infectious Diseases Product Offered
Table 82. Sysmex IVD Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Sysmex Main Business
Table 84. Sysmex Latest Developments
Table 85. Orasure Details, Company Type, IVD Infectious Diseases Area Served and Its Competitors
Table 86. Orasure IVD Infectious Diseases Product Offered
Table 87. Orasure IVD Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Orasure Main Business
Table 89. Orasure Latest Developments
Table 90. Hologic Details, Company Type, IVD Infectious Diseases Area Served and Its Competitors
Table 91. Hologic IVD Infectious Diseases Product Offered
Table 92. Hologic IVD Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Hologic Main Business
Table 94. Hologic Latest Developments
Table 95. Cepheid Details, Company Type, IVD Infectious Diseases Area Served and Its Competitors
Table 96. Cepheid IVD Infectious Diseases Product Offered
Table 97. Cepheid IVD Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Cepheid Main Business
Table 99. Cepheid Latest Developments
Table 100. Qiagen Details, Company Type, IVD Infectious Diseases Area Served and Its Competitors
Table 101. Qiagen IVD Infectious Diseases Product Offered
Table 102. Qiagen IVD Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Qiagen Main Business
Table 104. Qiagen Latest Developments
Table 105. Roche Diagnostics Details, Company Type, IVD Infectious Diseases Area Served and Its Competitors
Table 106. Roche Diagnostics IVD Infectious Diseases Product Offered
Table 107. Roche Diagnostics IVD Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. Roche Diagnostics Main Business
Table 109. Roche Diagnostics Latest Developments
Table 110. Siemens Healthcare Details, Company Type, IVD Infectious Diseases Area Served and Its Competitors
Table 111. Siemens Healthcare IVD Infectious Diseases Product Offered
Table 112. Siemens Healthcare IVD Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Siemens Healthcare Main Business
Table 114. Siemens Healthcare Latest Developments
Table 115. Bio-Rad Laboratories Details, Company Type, IVD Infectious Diseases Area Served and Its Competitors
Table 116. Bio-Rad Laboratories IVD Infectious Diseases Product Offered
Table 117. Bio-Rad Laboratories IVD Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. Bio-Rad Laboratories Main Business
Table 119. Bio-Rad Laboratories Latest Developments
LIST OF FIGURES
Figure 1. IVD Infectious Diseases Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global IVD Infectious Diseases Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. IVD Infectious Diseases Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. IVD Infectious Diseases Sales Market Share by Country/Region (2024)
Figure 8. IVD Infectious Diseases Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global IVD Infectious Diseases Market Size Market Share by Type in 2024
Figure 10. IVD Infectious Diseases in Clinical Laboratories
Figure 11. Global IVD Infectious Diseases Market: Clinical Laboratories (2020-2025) & ($ millions)
Figure 12. IVD Infectious Diseases in Diagnostic Centers
Figure 13. Global IVD Infectious Diseases Market: Diagnostic Centers (2020-2025) & ($ millions)
Figure 14. Global IVD Infectious Diseases Market Size Market Share by Application in 2024
Figure 15. Global IVD Infectious Diseases Revenue Market Share by Player in 2024
Figure 16. Global IVD Infectious Diseases Market Size Market Share by Region (2020-2025)
Figure 17. Americas IVD Infectious Diseases Market Size 2020-2025 ($ millions)
Figure 18. APAC IVD Infectious Diseases Market Size 2020-2025 ($ millions)
Figure 19. Europe IVD Infectious Diseases Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa IVD Infectious Diseases Market Size 2020-2025 ($ millions)
Figure 21. Americas IVD Infectious Diseases Value Market Share by Country in 2024
Figure 22. United States IVD Infectious Diseases Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada IVD Infectious Diseases Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico IVD Infectious Diseases Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil IVD Infectious Diseases Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC IVD Infectious Diseases Market Size Market Share by Region in 2024
Figure 27. APAC IVD Infectious Diseases Market Size Market Share by Type (2020-2025)
Figure 28. APAC IVD Infectious Diseases Market Size Market Share by Application (2020-2025)
Figure 29. China IVD Infectious Diseases Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan IVD Infectious Diseases Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea IVD Infectious Diseases Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia IVD Infectious Diseases Market Size Growth 2020-2025 ($ millions)
Figure 33. India IVD Infectious Diseases Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia IVD Infectious Diseases Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe IVD Infectious Diseases Market Size Market Share by Country in 2024
Figure 36. Europe IVD Infectious Diseases Market Size Market Share by Type (2020-2025)
Figure 37. Europe IVD Infectious Diseases Market Size Market Share by Application (2020-2025)
Figure 38. Germany IVD Infectious Diseases Market Size Growth 2020-2025 ($ millions)
Figure 39. France IVD Infectious Diseases Market Size Growth 2020-2025 ($ millions)
Figure 40. UK IVD Infectious Diseases Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy IVD Infectious Diseases Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia IVD Infectious Diseases Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa IVD Infectious Diseases Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa IVD Infectious Diseases Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa IVD Infectious Diseases Market Size Market Share by Application (2020-2025)
Figure 46. Egypt IVD Infectious Diseases Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa IVD Infectious Diseases Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel IVD Infectious Diseases Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey IVD Infectious Diseases Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries IVD Infectious Diseases Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 52. APAC IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 53. Europe IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 55. United States IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 56. Canada IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 57. Mexico IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 58. Brazil IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 59. China IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 60. Japan IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 61. Korea IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 63. India IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 64. Australia IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 65. Germany IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 66. France IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 67. UK IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 68. Italy IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 69. Russia IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 70. Egypt IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 71. South Africa IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 72. Israel IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 73. Turkey IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 74. Global IVD Infectious Diseases Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global IVD Infectious Diseases Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 1. IVD Infectious Diseases Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global IVD Infectious Diseases Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. IVD Infectious Diseases Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. IVD Infectious Diseases Sales Market Share by Country/Region (2024)
Figure 8. IVD Infectious Diseases Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global IVD Infectious Diseases Market Size Market Share by Type in 2024
Figure 10. IVD Infectious Diseases in Clinical Laboratories
Figure 11. Global IVD Infectious Diseases Market: Clinical Laboratories (2020-2025) & ($ millions)
Figure 12. IVD Infectious Diseases in Diagnostic Centers
Figure 13. Global IVD Infectious Diseases Market: Diagnostic Centers (2020-2025) & ($ millions)
Figure 14. Global IVD Infectious Diseases Market Size Market Share by Application in 2024
Figure 15. Global IVD Infectious Diseases Revenue Market Share by Player in 2024
Figure 16. Global IVD Infectious Diseases Market Size Market Share by Region (2020-2025)
Figure 17. Americas IVD Infectious Diseases Market Size 2020-2025 ($ millions)
Figure 18. APAC IVD Infectious Diseases Market Size 2020-2025 ($ millions)
Figure 19. Europe IVD Infectious Diseases Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa IVD Infectious Diseases Market Size 2020-2025 ($ millions)
Figure 21. Americas IVD Infectious Diseases Value Market Share by Country in 2024
Figure 22. United States IVD Infectious Diseases Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada IVD Infectious Diseases Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico IVD Infectious Diseases Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil IVD Infectious Diseases Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC IVD Infectious Diseases Market Size Market Share by Region in 2024
Figure 27. APAC IVD Infectious Diseases Market Size Market Share by Type (2020-2025)
Figure 28. APAC IVD Infectious Diseases Market Size Market Share by Application (2020-2025)
Figure 29. China IVD Infectious Diseases Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan IVD Infectious Diseases Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea IVD Infectious Diseases Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia IVD Infectious Diseases Market Size Growth 2020-2025 ($ millions)
Figure 33. India IVD Infectious Diseases Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia IVD Infectious Diseases Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe IVD Infectious Diseases Market Size Market Share by Country in 2024
Figure 36. Europe IVD Infectious Diseases Market Size Market Share by Type (2020-2025)
Figure 37. Europe IVD Infectious Diseases Market Size Market Share by Application (2020-2025)
Figure 38. Germany IVD Infectious Diseases Market Size Growth 2020-2025 ($ millions)
Figure 39. France IVD Infectious Diseases Market Size Growth 2020-2025 ($ millions)
Figure 40. UK IVD Infectious Diseases Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy IVD Infectious Diseases Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia IVD Infectious Diseases Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa IVD Infectious Diseases Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa IVD Infectious Diseases Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa IVD Infectious Diseases Market Size Market Share by Application (2020-2025)
Figure 46. Egypt IVD Infectious Diseases Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa IVD Infectious Diseases Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel IVD Infectious Diseases Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey IVD Infectious Diseases Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries IVD Infectious Diseases Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 52. APAC IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 53. Europe IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 55. United States IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 56. Canada IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 57. Mexico IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 58. Brazil IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 59. China IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 60. Japan IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 61. Korea IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 63. India IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 64. Australia IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 65. Germany IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 66. France IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 67. UK IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 68. Italy IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 69. Russia IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 70. Egypt IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 71. South Africa IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 72. Israel IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 73. Turkey IVD Infectious Diseases Market Size 2026-2031 ($ millions)
Figure 74. Global IVD Infectious Diseases Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global IVD Infectious Diseases Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries IVD Infectious Diseases Market Size 2026-2031 ($ millions)
More Publications
Global IVD Infectious Disease Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
US$ 3,480.00
October 2018
117 pages
Global IVD Infectious Disease Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
February 2024
112 pages